Significance
We generated mouse models that express mutations in high-confidence genes linked to Tourette disorder (TD). Traditional measures of behavior plus machine learning approaches reveal sensorimotor and cognitive-behavioral phenotypes. Sensorimotor gating deficits and repetitive motor behaviors are attenuated by drugs that act on dopamine. Reward learning and striatal dopamine are enhanced. Brain development, including cortical layering and patterning of major axon tracts, is grossly normal. No signs of striatal interneuron loss are detected. Interestingly, behavioral phenotypes in affected females can be more pronounced than in males, despite male sex bias in the diagnosis of TD. These unique mouse models with true construct validity provide a new resource to study neural substrates that cause tics and related behavioral phenotypes in TD.
Keywords: Tourette disorder, mouse models, behavior, neuroanatomical findings
Abstract
Tourette disorder (TD) is poorly understood, despite affecting 1/160 children. A lack of animal models possessing construct, face, and predictive validity hinders progress in the field. We used CRISPR/Cas9 genome editing to generate mice with mutations orthologous to human de novo variants in two high-confidence Tourette genes, CELSR3 and WWC1. Mice with human mutations in Celsr3 and Wwc1 exhibit cognitive and/or sensorimotor behavioral phenotypes consistent with TD. Sensorimotor gating deficits, as measured by acoustic prepulse inhibition, occur in both male and female Celsr3 TD models. Wwc1 mice show reduced prepulse inhibition only in females. Repetitive motor behaviors, common to Celsr3 mice and more pronounced in females, include vertical rearing and grooming. Sensorimotor gating deficits and rearing are attenuated by aripiprazole, a partial agonist at dopamine type II receptors. Unsupervised machine learning reveals numerous changes to spontaneous motor behavior and less predictable patterns of movement. Continuous fixed-ratio reinforcement shows that Celsr3 TD mice have enhanced motor responding and reward learning. Electrically evoked striatal dopamine release, tested in one model, is greater. Brain development is otherwise grossly normal without signs of striatal interneuron loss. Altogether, mice expressing human mutations in high-confidence TD genes exhibit face and predictive validity. Reduced prepulse inhibition and repetitive motor behaviors are core behavioral phenotypes and are responsive to aripiprazole. Enhanced reward learning and motor responding occur alongside greater evoked dopamine release. Phenotypes can also vary by sex and show stronger affection in females, an unexpected finding considering males are more frequently affected in TD.
Tourette disorder (TD) is characterized by tics; fast, recurrent movements, and vocalizations that wax and wane over time. Tics are frequently precipitated by unpleasant sensations and urges, with the tic providing relief (1, 2). Chronic tic disorders (CTD), a broad category that includes TD, are estimated to affect ~1/50 school-aged children in the United States and China (3–5). Common comorbidities include obsessive-compulsive, attention-deficit hyperactivity, and autism spectrum disorders, in addition to mood, anxiety, and sleep disorders (6). The constellation of neurological and neuropsychiatric conditions associated with TD/CTD impact social well-being, scholastic performance, and overall quality of life, posing increased risk for substance abuse, experiencing violent assault, and/or suicide (7–10). Yet, treatments are limited and frequently cause unwanted side effects.
Animal models are needed to help identify the underlying neuronal substrates, affected brain regions, and circuit mechanisms that cause tics and related behaviors in TD. However, ascribing changes in brain activity to behavioral phenotypes in the absence of a precise genetic change or neuronal lesion found in an affected human confounds our ability to confidently test these mechanisms. As such, a lack of animal models possessing construct validity for TD has hindered progress in the field. Most TD animal models reported to date either lack construct validity or attempt to model “TD-like” phenotypes in the absence of bona fide gene mutations that are associated with the human disorder. Developing animal models with true construct validity necessitates identifying genetic variants in high-confidence human risk genes.
The Tourette International Collaborative Genetics (TIC Genetics) study was established in 2011 to elucidate the genetic architecture of CTDs, including TD (11). Whole-exome sequencing of over 800 CTD/TD simplex/multiplex families identified multiple, individually distinct, rare de novo mutations in six genes from unrelated probands. These included likely gene-function disrupting single nucleotide variants, insertion-deletion mutations, and copy number variants (12, 13). Rare de novo variants are enriched in CTD/TD simplex trios and are estimated to produce greater than 10% of cases (12). Rare variants, as opposed to more common variants found in genome-wide association studies, have larger effect sizes and thus are strong candidates for animal models. Two putative TD genes that meet high-confidence criteria [false discovery rate (FDR) < 0.1], CELSR3 and WWC1 (also known as KIBRA), are intriguing candidates because of their roles in brain development, expression in cortico-striato-thalamo-cortical circuits, and/or synaptic functions (14–19).
We used CRISPR/Cas9 gene editing to engineer mice that express mutations identical to the de novo mutations found in CELSR3 and WWC1 from TD probands. These models possess construct validity, thereby constituting a significant advance in the field. Using traditional measures of mouse behavior, we characterize sensorimotor gating deficits, hyperactivity, and repetitive-like motor behaviors, which can show sex-dependent variable expressivity. Aripiprazole administration can attenuate sensorimotor gating deficits and repetitive-like rearing behavior. Using machine learning, we also see changes to the patterning and execution of spontaneous motor behavior. Instrumental learning paradigms suggest reward learning is enhanced in Celsr3 models, and electrically evoked dopamine (DA) release is greater in the striatum. Brain development is otherwise grossly normal and we do not detect striatal interneuron loss. These unique genetic models with construct validity show how mutations in high-confidence TD genes impact mouse behavior, providing possible outcome phenotypes for medication trials.
Results
Generation of TD Mouse Models with true Construct Validity.
CRISPR/Cas9 genome editing was used to introduce orthologous human mutations into coding exons for mouse Celsr3 and Wwc1 (12) (Fig. 1 A and D and SI Appendix, Fig. S1 A and B). For Celsr3, we engineered a nonsynonymous cysteine to tyrosine substitution within the second laminin G-like repeat, corresponding to human and mouse residues C1915Y (RefSeq: NP_001398.2) and C1906Y (RefSeq: NP_001346501.1), respectively. We also introduced a base-pair insertion corresponding to a frameshift mutation within the second laminin G-like repeat of human (coding 5706dupC, protein G1903Rfs*106) and mouse (coding 5679dupC, protein S1894Rfs*2). The human and mouse insertions cause stop-gain mutations within the second laminin G-like repeat (Fig. 1A and SI Appendix, Fig. S1A). Heterozygous Celsr3C1906Y/+ and Celsr3p.S1894Rfs*2/+ mice were viable but homozygotes died at birth, consistent with Celsr3 knockout mice and loss-of-function effects on the protein (14, 20). Celsr3 protein from whole-brain lysates was reduced in Celsr3S1894Rfs*2/+ mice. We did not observe truncated protein, suggesting that the mutation acts as a hypomorph by causing nonsense mediated mRNA decay and/or protein misfolding and degradation. Interestingly, protein levels were increased in Celsr3C1906Y/+ mice (Fig. 1 B and C and SI Appendix, Fig. S1 C–E). This suggests that the C1906Y amino acid substitution may exert dominant-negative effects as Celsr3 is thought to form homophilic interactions via its n-terminal cadherin repeats, forming a complex that directs proper membrane localization of planar cell polarity (PCP) signaling proteins (21). For Wwc1, we introduced a nonsynonymous tryptophan to cysteine substitution corresponding to human (RefSeq: NP_001155133.1) and mouse (RefSeq:NP_740749.1) residue W88C (Fig. 1D and SI Appendix, Fig. S1B). Heterozygous Wwc1W88C/+ mice were viable and fertile, and protein levels from whole-brain lysates were normal (Fig. 1E).
Celsr3 and Wwc1 Mutant Mice Have Sensorimotor Gating Deficits.
Sensorimotor gating deficits, as measured by prepulse inhibition (PPI), are reported in humans with TD, and also in Hdc knockout mice which model a stop gain mutation found in a single TD family (22–25). We assessed whether Celsr3 and Wwc1 transgenic mice had deficits in PPI of the acoustic startle reflex (SI Appendix, Table S1). PPI was reduced in both Celsr3C1906Y/+ females [F(1, 23) = 5.49, P = 0.028] and males [F(1, 25) = 7.48, P = 0.011] (Fig. 2A). Baseline acoustic startle responses were normal (SI Appendix, Fig. S2A). PPI was also reduced in Celsr3S1894Rfs*2/+ females [F(1, 39) = 4.25, P = 0.046] and males [F(1, 33) = 5.8, P = 0.02] (Fig. 2B). Baseline acoustic startle responses were normal in Celsr3S1894Rfs*2/+ males but decreased in females (P = 0.033). We did not detect an association between reduced startle and levels of inhibition (r = 0.252 and P = 0.21, Spearman correlation coefficient) (SI Appendix, Fig. S2 B and C). Acoustic PPI was also slightly decreased in Wwc1W88C/+ females [F(1, 36) = 3.9, P = 0.056], who had normal baseline startle responses. Wwc1W88C/+ males showed normal PPI and baseline startle responses [F(1,40) = 0.395, P = 0.53] (Fig. 2C and SI Appendix, Fig. S2D).
PPI Deficits in Celsr3 Female Mice Are Attenuated by Aripiprazole.
We tested whether PPI deficits in female Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ mice were responsive to aripiprazole, a partial agonist at dopamine type II and serotonin 5-HT1a receptors that is prescribed for TD. For the former group, we did not see a significant effect of treatment on levels of inhibition (P = 0.44). We observed a trend-level effect of genotype (P = 0.093) and a significant treatment (x) genotype interaction (P = 0.017). For the latter, we also did not see a significant effect of treatment on levels of inhibition (P = 0.66). We once again observed a trend-level effect of genotype (P = 0.064) and a significant treatment (x) genotype interaction (P = 0.013) (Fig. 2 D and E). Baseline startle responses were similar between controls and mutants treated with either vehicle or drug (SI Appendix, Fig. S2 E and F). Thus, PPI deficits appear responsive to aripiprazole, suggesting perturbations to dopamine and/or serotonin may contribute to sensorimotor gating deficits in Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ mice.
Celsr3 Mutants Perform Better on an Accelerating Rotarod.
Mice were tested on an accelerating rotarod to assess changes to motor coordination and balance (Fig. 3A and SI Appendix, Table S1). Celsr3C1906Y/+ mice displayed a longer latency to fall compared with wild-type littermates [males F(1, 30) = 6.673, P = 0.015); females F(1, 32) = 3.921, P = 0.056]. Celsr3S1894Rfs*2/+ males also showed a longer latency to fall [F(1, 41) = 4.022, P = 0.051], but Celsr3S1894Rfs*2/+ females showed no differences compared to littermate controls. We did not detect changes to rotarod performance for Wwc1W88C/+ mice (Fig. 3A). These results show that motor coordination and balance are improved in Celsr3 mutants and may also suggest changes to motor learning and execution.
Celsr3 Mutants Are More Active and Show Enhanced Rearing Behavior in the Open Field.
We assessed behavior while mice navigated an open-field arena for 30 min (SI Appendix, Table S1). Celsr3C1906Y/+ females were more active and traveled more total distance compared to controls [F(1, 30) = 6.4, P = 0.017], whereas Celsr3C1906Y/+ males showed a trend-level effect [F(1, 30) = 2.9, P = 0.09] (Fig. 3B). Latency to enter the center of the arena was similar for Celsr3C1906Y/+ mice compared to controls (SI Appendix, Fig. S3A). Celsr3C1906Y/+ females made more center zone entries over time [Time × genotype effect: F(2, 60) = 5.693, P = 0.005], whereas males showed a weak trend [Time × genotype effect: F(2, 60) = 2.04, P = 0.139] (SI Appendix, Fig. S3B). Thus, Celsr3C1906Y/+ mice, particularly females, are more active in the open field. Exploratory behavior may also be increased in females, as reflected by the greater number of center zone entries as time progressed.
Next, we looked at the number of vertical rearing events and time spent rearing. The cumulative number of rearing events was increased for Celsr3C1906Y/+ females [F(1, 30) = 9.1, P = 0.003], as was total time spent rearing [F(1, 30) = 4.374, P = 0.045] (SI Appendix, Fig. S4 A and B). Rearing events also showed significant or near-significant increases when analyzed separately within binned intervals (0 to 10 min, P = 0.002; 10 to 20 min, P = 0.046; 20 to 30 min, P = 0.074) (Fig. 3C). However, except for the first 10 min, time spent rearing within these intervals was not significantly different (0 to 10 min, P = 0.045; 10 to 20 min, P = 0.22; 20 to 30 min, P = 0.73) (Fig. 3C). This suggests that some vertical rears may have been briefer and more repetitive-like. Celsr3C1906Y/+ males displayed a trend for more rearing events across binned intervals [F(1, 30) = 3.6, P = 0.067)] (Fig. 3C). Rearing counts were especially increased during the first 10 min (0 to 10 min, P = 0.005); however, time spent rearing was not different (P = 0.2) (Fig. 3C and SI Appendix, Fig. S4B). This suggests that Celsr3C1906Y/+ males may also show some repetitive-like rearing. For males and females, rearing counts along the perimeter of the arena were increased (females, P = 0.001 and males, P = 0.023) (SI Appendix, Fig. S4D).
Celsr3S1894Rfs*2/+ female and male mice traveled similar distances in the open field compared to wild-type mice [Female: F(1, 41) = 1.9, P = 0.17, Male: F(1, 39) = 0.61, P = 0.42] (Fig. 3B). Latency to enter the center of the arena was shorter for Celsr3S1894Rfs*2/+ females (P = 0.073), whereas males showed no differences versus controls (SI Appendix, Fig. S3C). Celsr3S1894Rfs*2/+ females also showed a trend-level effect for more center zone entries [F(1, 41) = 3.61, P = 0.065], but no changes were observed for Celsr3S1894Rfs*2/+ males [F(1, 39) = 0.1922, P = 0.664] (SI Appendix, Fig. S3D). The cumulative number of rearing events [F(1, 41) = 10.8, P = 0.002] and total time spent rearing [F(1, 41) = 8.09, P = 0.007] were also greater for Celsr3S1894Rfs*2/+ females (SI Appendix, Fig. S4 E and F). Significant or near-significant differences in the number of rearing events were seen within binned 10-min intervals (0 to 10 min P = 0.004, 11 to 20 min P = 0.043, and 21 to 30 min P = 0.098) (Fig. 3C). However, time spent rearing was similar to controls within the first and second intervals, similar to Celsr3C1906Y/+ females (0 to 10 min P = 0.13, 10 to 20 min P = 0.22) (SI Appendix, Fig. S4G). The cumulative number of rearing events [F(1, 39) = 4.618, P = 0.038] and total time spent rearing [F(1, 39) = 4.998, P = 0.031] were also increased for Celsr3S1894Rfs*2/+ males but to a lesser extent versus females (SI Appendix, Fig. S4 E and F). The number of rearing events was also significantly increased when measured separately within and across binned intervals [F(1, 39) = 5.8, P = 0.021] (Fig. 3C). Rearing events along the perimeter and center both trended upward for Celsr3S1894Rfs*2/+ mice (SI Appendix, Fig S4H). Thus, like Celsr3C1906Y/+ mutants, Celsr3S1894Rfs*2/+ males—and especially females—rear more in the open field.
Wwc1W88C/+ males also traveled more distance in the open field [F(1, 29) = 5, P = 0.033]. Wwc1W88C/+ females, by contrast, traveled similar distances versus controls (Fig. 3B). Latency to enter the center of the arena and number of entries was unaffected for both sexes (SI Appendix, Fig. S3 E and F). Wwc1W88C/+ males also showed more cumulative rearing events [F(1, 29) = 4.2, P = 0.048] and a trend for increased time spent rearing [F(1, 29) = 3.6, P = 0.06] (SI Appendix, Fig. S4 I and J). When measured across binned intervals, we saw trend-level effects for the number of rearing events [F(1, 29) = 3.6, P = 0.066] and time spent rearing [F(1, 29) = 3.4, P = 0.076] (Fig. 3D and SI Appendix, Fig. S4K). We did not observe a preference for rearing along the perimeter versus the center (SI Appendix, Fig. S4L). Rearing behavior was normal for Wwc1W88C/+ females, in stark contrast to Celsr3 female mutants (Fig. 3C and SI Appendix, Fig. S4 I–L). Thus, Wwc1W88C/+ males are slightly more active and rear more in the open field, while females behave similarly to controls.
Aripiprazole Attenuates Rearing Behavior in the Open Field.
Aripiprazole is efficacious for reducing tics in TD subjects and is the preferred drug of choice in children and adolescents (26). Additionally, administration in mice (≥1 mg/kg) reduces rearing behavior in the open field (27). We tested whether aripiprazole pretreatment could attenuate repetitive rearing behavior for Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ mice, focusing on females who showed more pronounced changes. Aripiprazole treatment at dosages of 0.3 mg/kg or 0.5 mg/kg reduced the distance traveled in the open field for both wild-type and mutant mice (SI Appendix, Fig. S3 C, D, G, and H), consistent with previous findings in mice and sedation that can occur in humans (26, 27). Rearing counts were once again increased for vehicle-treated mutants (both genotypes) versus vehicle-treated controls (SI Appendix, Table S1). Aripiprazole reduced the number of rearing events for drug-treated versus vehicle-treated controls, as well as for drug-treated versus vehicle-treated mutants (both genotypes). We observed significant effects of genotype (P < 0.0001) and treatment (P < 0.0001) on rearing events for Celsr3C1906Y/+ and also Celsr3S1894Rfs*2/+ mice (genotype, P < 0.0001; treatment, P < 0.0001), but no significant drug (x) genotype interactions as aripiprazole had similar effects on both mutant and wild-type mice (Fig. 3D). Nonetheless, post hoc testing showed that differences were no longer significant for vehicle-treated controls versus drug-treated mutants (both genotypes) across each binned interval (Fig. 3D). Thus, repetitive rearing behavior in mutant Celsr3 females is attenuated by aripiprazole, approaching levels more consistent with vehicle-treated controls, but these results need to be interpreted with caution given the sedative effects of the drug.
Grooming Events Are Increased for Celsr3 Mutants.
The number of grooming bouts, total time spent grooming, and average bout duration were measured in the open field (SI Appendix, Table S1). The total number of grooming bouts was increased for Celsr3C1906Y/+ (P = 0.001) and Celsr3S1894Rfs*2 females (P = 0.0005) (Fig. 3E). Hair loss was sometimes found behind the ears and back of the neck, but no lesions (SI Appendix, Fig. S5A). Total time spent grooming was also increased for females (Celsr3C1906Y/+, P = 0.052; Celsr3S1894Rfs*2/+ P = 0.001) (SI Appendix, Fig. S5 B and C). The average duration of each grooming bout was comparable to controls, suggesting that sequential, stereotypic grooming sequences are not interrupted (SI Appendix, Fig. S5 B and C). The number of grooming bouts was also increased for both Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ males (P = 0.082 and P = 0.045, respectively) (Fig. 3E). We did not detect significant changes to total time spent grooming nor the average duration of each grooming event, although the latter trended shorter in Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ males (SI Appendix, Fig. S5 B and C). The number of grooming bouts, total time spent grooming, and average grooming bout duration were normal in male and female Wwc1W88C/+ mice (Fig. 3E and SI Appendix, Fig. S5D). Repetitive digging behaviors were also assessed using the marble burying assay. We did not observe any significant enhancement for either Celsr3 or Wwc1 mutant (SI Appendix, Fig. S6). Thus, increased grooming, in addition to rearing, constitute motor phenotypes that are prominent in Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ females but, interestingly, less so in males.
Unsupervised Machine Learning Reveals Changes to Spontaneous Motor Behavior.
We characterized changes to spontaneous motor behavior using Motion Sequencing (MoSeq). MoSeq uses 3D depth imaging and unsupervised machine learning to parse motor behavior into the sequential expression of reusable and stereotyped behaviors (i.e., syllables) while mice navigate a circular open field (28) (Fig. 4A). These syllables typically last a few hundred milliseconds and estimates for syllable usage frequency and duration can be measured. Further, MoSeq can assess how behavior is organized through analysis of transition probabilities and syllable sequence entropy (i.e., how mice arrange syllables into patterned movement sequences across time), advantageous for movement disorders like TD. Cotraining MoSeq with data from each model revealed numerous changes to syllable usage frequencies in mutant mice. In male and female Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ mice, shared syllables corresponding to rearing (both assisted and unassisted) were generally up-regulated (Fig. 4 B, i–vi). Conversely, syllables corresponding to pauses were generally down-regulated, perhaps reflecting their overall tendency to be more active. Changes to syllable usages were less prominent in Wwc1W88C/+ mice and did not substantially overlap with Celsr3 mutant mice (Fig. 4 B, v and vi SI Appendix, Table S2).
We used linear discriminant analysis (LDA) to learn a low-dimensional (2D) mouse embedding, trained on syllable usages, to better visualize and categorize mice across sex and genotype. The LDA projection for Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ males and females showed good separation by sex and genotype from their respective controls, whereas Wwc1W88C/+ mice were less segregated from littermate controls (Fig. 4 C and D). We found that these models could predict the sex and genotype of held-out mice with high accuracy, which was ablated by randomization of group labels, indicating that a true relationship exists between the genotype, sex of mice, and the syllable usage values they emit (Celsr3C1906Y model: accuracy on held-out data = 0.56, permutation test P = 9.99e-4; Celsr3S1894Rfs*2 model: accuracy on held-out data = 0.85, permutation test P = 9.99e-4) (SI Appendix, Fig. S7). We also computed the cosine distance within- and between-groups to further probe group separability within the high-dimensional syllable usage space. The between-group cosine distance for all sexes and genotypes exceeded the within-group cosine distances in all cases (SI Appendix, Fig. S8). This indicates that, overall, members of each group defined by mouse line, sex, and genotype are closer to each other than mice from another group in the high-dimensional syllable usage space.
Syllable usage entropy revealed mutant mice displayed lower entropy relative to controls (Fig. 5 A, Left). This indicates that spontaneous motor behavior is less diverse on average, which might be expected with increased expression of repetitive behaviors (e.g., rearing). However, syllable sequence entropy rate was increased, suggesting the transitions between motor sequences, reflecting motor planning or action selection strategies that regulate patterned movements across time, were more disorganized and/or unpredictable (29) (Fig. 5 A, Right). When comparing state maps of relative changes to transition probabilities between mutants and controls, some commonly altered transitions between certain syllables are apparent across multiple mutant lines (Fig. 5B). Altogether, these findings suggest that Celsr3 mutant mice favor certain behaviors at the expense of others, but the action selection strategies to reach these more favored states become less predictable. Additionally, mutant mice are discriminated from normal behaving controls according to their respective syllable usage frequencies and transition probabilities.
Reward Learning and Evoked Dopamine Release Are Enhanced in Celsr3 Mutants.
Reward learning is suggested to be altered in humans with TD but, to our knowledge, has not been investigated in animal models (30). Given changes to sensorimotor behavior seen in Celsr3 mutant mice, we next wanted to assess whether goal-driven behavior was also affected. We examined motor responding and reward learning in Celsr3C1906Y/+ males and Celsr3S1894Rfs*2/+ females (consistent with the sex of the affected proband) using a continuous, fixed-ratio reinforcement schedule (SI Appendix, Table S1). In this assay, repeated over a span of four days, mice have 90 min to earn a total of thirty sucrose pellets, with one pellet earned for each nose poke. Upon examining rewarded nose poke timestamps across individual trials, Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ mice showed elevated motor responding compared to wild-type littermates (Fig. 6A). The rate of cumulative rewards obtained was significantly enhanced on all four days of testing for Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ mice (P < 0.0001), as determined by linear (day 1, R2 > 0.99) and nonlinear regression analysis (days 2 to 4, R2 > 0.98) (Fig. 6B). The mean time spent to obtain thirty rewards was reduced in Celsr3C1906Y/+ mice on day 3 (P = 0.03) and in Celsr3S1894Rfs*2/+ mice on days two (P = 0.04) and three (P = 0.03, Fig. 6C). Analyzed across all four days, mean time to completion was significantly shorter [Celsr3C1906Y/+, F(1, 219) = 4.998, P = 0.026; Celsr3S1894Rfs*2/+, F(1, 191) = 11.43, P = 0.0009]. Additionally, across days two through four, we saw a trend-level effect for reduced latency to retrieve first rewards, suggesting that motivation might be increased (Fig. 6C). We next measured changes to electrically evoked striatal dopamine using fast-scan cyclic voltammetry. Celsr3C1906Y/+ mice have higher peak evoked DA in the dorsal striatum compared to controls (P = 0.002, Fig. 6 D–J). The decay constant was normal (Fig. 6G). Thus, motor responding and reward learning are enhanced in Celsr3 mutants, potentially due to effects on striatal dopamine.
Brain Development Is Grossly Normal without Signs of Striatal Interneuron Loss.
Celsr3 is required for axon pathfinding and the development of forebrain commissures (20). Cortical and striatal interneuron migration defects have also been reported in homozygous Celsr3GFP mice, in which GFP is knocked into the endogenous locus, ablating protein functions (14). We looked for signs of striatal interneuron loss in Celsr3 and Wwc1 mutant mice. We did not detect changes in density or nearest neighbor distance for parvalbumin-expressing interneurons (Fig. 7 A–F). Crossing Celsr3S1894Rfs*2/+ and Celsr3C1906Y/+ mice with a transgenic reporter line that expresses green fluorescent protein (eGFP) in choline acetyltransferase (ChAT) expressing cells, or antibody labeling against ChAT in Wwc1W88C mice, did not reveal changes in density or the nearest neighbor distance for striatal cholinergic interneurons (Fig. 7 A–F). We also assessed overall cellular organization and development of major axon tracts in Celsr3S1894Rfs*2/+ mice. Nissl staining showed grossly normal organization of cortical and subcortical regions (SI Appendix, Fig. S8A). Crossing a genetic reporter line that expresses red fluorescent protein (tdTomato) in dopamine receptor type 1 (Drd1a) expressing striatonigral fibers did not reveal any major changes to axon fiber trajectory (SI Appendix, Fig. S8B). Cortical layering, thickness, and within-layer cell density were normal, as determined by immunolabeling for transcription factors Ctip2, Satb2, and Foxp2 (SI Appendix, Fig. S8C). Thus, brain development is grossly normal in Celsr3S1894Rfs*2/+ mice, and striatal interneuron loss is not detected in all three models.
Discussion
Few genetic models have been developed for TD. Heterozygous Ash1l and homozygous histidine decarboxylase (Hdc) knockout mice possess validity at the gene level, although they do not model the exact human mutations (22, 31). Similar to our models, Ash1l+/− mice show elevated grooming, whereas Hdc−/− mice have PPI deficits (31). However, PPI deficits have not been reported in Ash1l+/− mice and Hdc−/− mice do not show repetitive motor behaviors at baseline. Our testing suggests that Wwc1W88C/+ females may converge more closely with Hdc−/− mice, whereas Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ mice show behavioral phenotypes consistent with both Ash1l+/− and Hdc−/− mice, suggesting that they provide distinct advantages for modeling TD. PPI deficits are the most consistent finding between ours and the aforementioned models and may reflect a core behavioral phenotype in TD mice.
Despite detecting changes to motor behavior and cognitive functions, brain development was grossly normal in Celsr3S1894Rfs*2 mice, and striatal interneuron loss was not detected in all three models. Furthermore, striatal interneuron loss is absent in more mildly affected Celsr3R774H/R774H mice reported elsewhere, in agreement with findings from Hdc−/−and Ash1l+/− mice (31–33). Notably, striatal interneuron loss was reported in postmortem tissue from a small cohort of adults with severe, refractory TD whose gene mutations, if any, were unknown (34, 35). A follow-up study using brain organoids grown from patient-derived iPSCs (without identified gene mutations) also showed interneuron loss (36). These studies are widely cited to explain the neuropathology of TD and have motivated the development of animal models based on diphtheria-toxin-mediated interneuron ablation or bicuculline disinhibition in the striatum (37–42). Although these studies have provided interesting insights, these putative models lack construct validity, do not recapitulate neurodevelopmental changes, and phenotypes can be mixed and/or subtle. Collectively, findings from multiple genetic models suggest that striatal interneuron loss is rare in TD, perhaps limited only to severely affected adults.
Dopamine imbalances affecting fronto-cortico-striatal circuits are suspected in TD, despite limited direct evidence for DA involvement (43–51). Antipsychotic medications that act on dopamine D2 receptors (e.g., haloperidol and aripiprazole) are effective for reducing tics in some (44, 52). Dysregulated striatal dopamine is also suspected in Hdc−/− and Ash1l+/− knockout mice, with some repetitive motor behaviors responsive to haloperidol (22, 31). Certain behavioral phenotypes in Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ mice, including enhanced rearing and improved rotarod performance, are also suggestive of altered striatal dopamine (53, 54). Moreover, rearing behavior was attenuated by aripiprazole (albeit in both mutants and controls). Enhanced motor responding and reward learning under fixed reinforcement also suggest striatal dopamine levels may be higher. Indeed, electrically evoked dopamine release was increased in the dorsal striatum of Celsr3C1906Y/+ mice. In addition to dorsal regions that control action-outcome learning and sensorimotor behavior, our results suggest affection to limbic regions, causing stronger motivational drive and/or reward perception (55–57). Higher levels of dopamine may enhance the perceived and/or anticipated rewarding effects of tics in response to premonitory urges. Over time, this may potentiate stimulus–response associations that produce the “urge-to-tic” in certain environments, contexts, or emotional states. In this sense, tics may be maladaptive habits learned to alleviate unpleasant sensations and urges (58). Furthermore, dopamine stimulation and/or in vivo recordings paired with MoSeq show larger dopamine transients can reinforce syllable usages and ordering, promoting more variable behavioral sequences (i.e., higher sequence entropy rate) via effects on transition probabilities that govern syllable switching (59). Similarly, the observed changes we see with syllable usages, transition probabilities, and sequence entropy in Celsr3 mutants may be indicative of altered dopamine transients influencing the probability of performing certain syllables over others, and how these are ordered across space and time.
The prevalence of TD is higher in males than females (~3-4:1), similar to autism spectrum disorder which shares some genetic overlap (6, 12, 60). While Celsr3C1906Y/+ and Celsr3S1894Rfs*2/+ males exhibit TD-like behaviors, in some instances the phenotypes appear stronger in females (e.g., hyperactivity, rearing, grooming), a somewhat unexpected finding. Moreover, Wwc1W88C/+ females, but not males, have PPI deficits. Interestingly, a study in humans with OCD reported prepulse inhibition deficits only in females (61). It is still uncertain whether more common comorbidities in males, especially ADHD, may facilitate earlier diagnosis, skewing the true male/female sex ratio in TD (62). Some studies suggest that sex bias in TD is less prominent in adults, and females may experience more compulsions, anxiety, and worsening of symptoms over time compared with males, who may be more likely to experience tic contraction (62–64). Our studies were limited to adult mice, and thus behavioral phenotypes could be overrepresented in adult females versus juveniles. Interestingly, damaging de novo variants are enriched in females from TD/CTD simplex families, especially in mutation-intolerant genes such as Celsr3 (12). This may explain why some phenotypes appear more penetrant in female mice. Celsr3S1894Rfs*2/+ was also identified in a female with early onset tics noted by age three. Thus, our genetic models may provide important insights into naturally occurring sex differences in TD and caution against selecting models or biasing studies toward males.
In summary, the most consistent findings in our genetic models are sensorimotor gating deficits and elevated rearing behavior in the open field. These phenotypes are attenuated by aripiprazole in females, but further studies are necessary to determine whether males show similar responses (a limitation of this study). Enhanced reward learning is a previously uncharacterized phenotype in TD mouse models and may reflect higher phasic dopamine release. Changes to spontaneous motor behavior and first-order transition probabilities between syllables discriminate patterned movement sequences between freely behaving TD mice versus wild-type controls. Notably, motor syllables are associated with distinct neuronal ensembles in the striatum, which may be reinforced by dopamine fluctuations (29, 59). While there is no clear consensus on what human tics look like in mice, leveraging these unbiased computational approaches could thus prove useful for high-throughput drug screening. Furthermore, pairing our models with genetic dopamine sensors (e.g., dLight) while they behave in various contexts (e.g., reward learning) may reveal new insights into neuronal substrates that underlie TD.
Materials and Methods
Animals.
Strains and testing are approved by Rutgers IACUC PROTO201702623 (M.A.T.) and IACUC PROTO999900331 (J.A.T.). Mice were maintained on pure C57BL6/J backgrounds (JAX #000664). F1 founders were backcrossed for at least six generations. Mice were maintained on normal light–dark cycles and tested during the light cycle. Mice were group housed with littermates and separated by sex and provided food and water ad libitum unless otherwise specified. Commercially available strains include Drd1a-tdTomato (RRID:IMSR_JAX:016204) and ChatBAC-eGFP (RRID:IMSR_JAX:007902). Complete details regarding mouse generation, DNA editing, and genotyping can be found in SI Appendix, Methods.
Mouse Behavior.
Prepulse inhibition was run as previously described using mice aged 8 to 12 wk (22). For rotarod, 6-wk-old mice completed an accelerated rotarod test (Harvard Apparatus) consisting of three trials per day for three consecutive days. Open-field activity of 8-wk-old mice was measured in an unfamiliar open-field arena with activity monitor software (Med. Associates, Env-520, legacy). For fixed reinforcement, male Celsr3C1906Y/+ and female Celsr3S1894Rfs*2/+ mice were tested in sound-attenuated operant chambers (Med Associates) under a fixed ratio-1 schedule lasting 90 min (or max 30 rewards) for four consecutive days. Nose poke time stamps and latency to reward retrieval were registered using Med-PC V (Med. Associates) and sessions were recorded. Complete descriptions for behavioral procedures can be found in SI Appendix, Methods.
Motion Sequencing.
Analysis was performed using standard methods (29) and as previously described (65). Mice, median age of 8 wk, were placed individually in an open-field arena and allowed to freely behave for 20 min while imaged from above with a Kinect v2 depth camera. Raw depth video was extracted, projected onto a common reference mouse to account for size differences, and projected onto a learned PCA embedding and modeled with autoregressive hidden Markov models (AR-HMM, a.k.a “MoSeq model”) on the first 10 PCs using a kappa found via search. Normalized syllable usage frequencies were tested using bootstrap tests with multiple testing correction by Benjamini–Hochberg procedure. Entropy and entropy rate were computed using standard formulas and tested using Mann–Whitney U test. Fivefold cross-validated 2D LDA models were trained with normalized usage frequencies and following best practices. Complete descriptions of analysis procedures are found in SI Appendix, Methods.
Mouse Histology and Striatal Interneuron Counts.
Mice (both sexes, 1 mo old) were transcardially perfused with 4% paraformaldehyde. Interneuron density was quantified in Imaris (Bitplane). Complete descriptions of all procedures, antibodies, and reagents can be found in SI Appendix, Methods.
Statistical Analyses.
Statistical analysis, with the exception of Motion Sequencing, was performed using Graphpad Prism (Graphpad Software Inc.). PPI was analyzed using two-way repeated measures ANOVA across all three prepulses. Spearman’s correlation coefficient was performed to determine whether correlations existed between startle amplitude and prepulse inhibition. Rotarod was analyzed across all nine trials using two-way ANOVA with repeated measures. Marble burying was analyzed using Mann–Whitney U test. Time spent grooming, time/grooming bout, and number of grooming events were analyzed using Mann–Whitney U test. Open-field distance traveled and rearing events were analyzed using two-way ANOVA with repeated measures and Bonferroni multiple correction testing. Unless otherwise noted, two-way ANOVA results are presented as the main effect of genotype. For reinforcement learning, Mann–Whitney U tests were used to compare time to completion, and t tests with Welch’s correction and Holm-Šídák’s multiple comparison correction were used to compare rewards obtained. For MoSeq behavioral usage and transition matrices, bootstrap analysis was performed followed by Benjamini–Hochberg multiple comparisons testing. LDA was completed using scikit-learn implementation. A complete description of all statistics and results for behavioral experiments are found in SI Appendix, Methods and Tables S1 and S2.
Supplementary Material
Acknowledgments
We acknowledge the Rutgers Genome Editing Facility (Peter Romanienko and Ghassan Yehia), Jaclyn Eisdorfer for discussions pertaining to raster plots and statistics, and Biorender.com for mouse schematics in Fig. 4 and SI Appendix, Fig. S9. Tourette Association of America (M.A.T.), New Jersey Center for Tourette Syndrome (M.A.T., G.A.H., and J.A.T.), Brain Research Foundation (#BRFSG-2022-11, M.A.T.), Robert Wood Johnson Foundation (#74260, M.A.T.), National Institutes of Mental Health R01MH115958 (J.A.T. and G.A.H.), NIH/NIMH U24 MH068457 (J.A.T.).
Author contributions
M.B. and M.A.T. designed research; C.N., L.A.P., J.W., T.F.K., R.W., A.P., M.M., S.L., R.S., C.K.J., and M.B. performed research; S.L. and F.T. contributed new reagents/analytic tools; C.N., L.A.P., J.W., T.F.K., J.K.T., R.W., D.G., and M.B. analyzed data; and G.A.H., J.A.T., and M.A.T. wrote the paper.
Competing interests
The authors declare no competing interest.
Footnotes
This article is a PNAS Direct Submission.
Data, Materials, and Software Availability
All study data are included in the article and/or SI Appendix. Additional raw data and information pertaining to MoSeq behavioral data sets and reward learning have been deposited at Zenodo and are publicly available as of the date of publication (66–69).
Supporting Information
References
- 1.Leckman J. F., King R. A., Bloch M. H., Clinical features of tourette syndrome and tic disorders. J. Obsessive Compuls. Relat. Disord. 3, 372–379 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Cavanna A. E., Black K. J., Hallett M., Voon V., Neurobiology of the premonitory urge in Tourette’s syndrome: Pathophysiology and treatment implications. J. Neuropsychiatry Clin. Neurosci. 29, 95–104 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Tinker S. C., Bitsko R. H., Danielson M. L., Newsome K., Kaminski J. W., Estimating the number of people with Tourette syndrome and persistent tic disorder in the United States. Psychiatry Res. 314, 114684 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Yan J., et al. , The prevalence and comorbidity of tic disorders and obsessive-compulsive disorder in Chinese school students aged 6–16: A National Survey. Brain Sci. 12, 650 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Heiman G. A., et al. , Empiric recurrence risk estimates for chronic tic disorders: Implications for genetic counseling. Front. Neurol. 11, 770 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Robertson M. M., A personal 35 year perspective on Gilles de la Tourette syndrome: Prevalence, phenomenology, comorbidities, and coexistent psychopathologies. Lancet Psychiatry 2, 68–87 (2015). [DOI] [PubMed] [Google Scholar]
- 7.Fernandez de la Cruz L., et al. , Suicide in Tourette’s and chronic tic disorders. Biol. Psychiatry 82, 111–118 (2017). [DOI] [PubMed] [Google Scholar]
- 8.Mataix-Cols D., et al. , Association of Tourette syndrome and chronic tic disorder with violent assault and criminal convictions. JAMA Neurol. 79, 459–467 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Virtanen S., et al. , Association of Tourette Syndrome and chronic tic disorder with subsequent risk of alcohol- or drug-related disorders, criminal convictions, and death: A population-based family study. Biol. Psychiatry 89, 407–414 (2021). [DOI] [PubMed] [Google Scholar]
- 10.Lund J., Borch-Johnsen L., Groth C., Skov L., Debes N. M., Impact of Tourette syndrome on education. Neuropediatrics 54, 107–112 (2022). [DOI] [PubMed] [Google Scholar]
- 11.Dietrich A., et al. , The Tourette International Collaborative Genetics (TIC Genetics) study, finding the genes causing Tourette syndrome: Objectives and methods. Eur. Child Adolesc Psychiatry 24, 141–151 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Wang S., et al. , De novo sequence and copy number variants are strongly associated with Tourette disorder and implicate cell polarity in pathogenesis. Cell Rep. 25, 3544 (2018). [DOI] [PubMed] [Google Scholar]
- 13.Willsey A. J., et al. , De novo coding variants are strongly associated with Tourette disorder. Neuron 94, 486–499.e9 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ying G., et al. , The protocadherin gene Celsr3 is required for interneuron migration in the mouse forebrain. Mol. Cell Biol. 29, 3045–3061 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wu J., Poppi L. A., Tischfield M. A., Planar cell polarity and the pathogenesis of Tourette Disorder: New hypotheses and perspectives. Dev. Biol. 489, 14–20 (2022). [DOI] [PubMed] [Google Scholar]
- 16.Stepan J., et al. , Hippo-released WWC1 facilitates AMPA receptor regulatory complexes for hippocampal learning. Cell Rep. 41, 111766 (2022). [DOI] [PubMed] [Google Scholar]
- 17.Makuch L., et al. , Regulation of AMPA receptor function by the human memory-associated gene KIBRA. Neuron 71, 1022–1029 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Thakar S., et al. , Evidence for opposing roles of Celsr3 and Vangl2 in glutamatergic synapse formation. Proc. Natl. Acad. Sci. U.S.A. 114, E610–E618 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Zhou Q., et al. , Celsr3 is required for Purkinje cell maturation and regulates cerebellar postsynaptic plasticity. iScience 24, 102812 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Tissir F., Bar I., Jossin Y., De Backer O., Goffinet A. M., Protocadherin Celsr3 is crucial in axonal tract development. Nat. Neurosci. 8, 451–457 (2005). [DOI] [PubMed] [Google Scholar]
- 21.Chen W. S., et al. , Asymmetric homotypic interactions of the atypical cadherin flamingo mediate intercellular polarity signaling. Cell 133, 1093–1105 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Baldan L. C., et al. , Histidine decarboxylase deficiency causes tourette syndrome: Parallel findings in humans and mice. Neuron 81, 77–90 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zebardast N., et al. , Brain mechanisms for prepulse inhibition in adults with Tourette syndrome: Initial findings. Psychiatry Res. 214, 33–41 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Swerdlow N. R., et al. , Tactile prepuff inhibition of startle in children with Tourette’s syndrome: In search of an “fMRI-friendly” startle paradigm. Biol. Psychiatry 50, 578–585 (2001). [DOI] [PubMed] [Google Scholar]
- 25.Castellanos F. X., et al. , Sensorimotor gating in boys with Tourette’s syndrome and ADHD: Preliminary results. Biol. Psychiatry 39, 33–41 (1996). [DOI] [PubMed] [Google Scholar]
- 26.Roessner V., et al. , European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: Pharmacological treatment. Eur. Child Adolesc. Psychiatry 31, 425–441 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Picada J. N., et al. , Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice. Acta Pharmacol. Sin. 32, 1225–1232 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wiltschko A. B., et al. , Mapping sub-second structure in mouse behavior. Neuron 88, 1121–1135 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Markowitz J. E., et al. , The striatum organizes 3D behavior via moment-to-moment action selection. Cell 174, 44–58 e17 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Palminteri S., et al. , Dopamine-dependent reinforcement of motor skill learning: Evidence from Gilles de la Tourette syndrome. Brain 134, 2287–2301 (2011). [DOI] [PubMed] [Google Scholar]
- 31.Liu S., et al. , Mutations in ASH1L confer susceptibility to Tourette syndrome. Mol. Psychiatry 25, 476–490 (2020). [DOI] [PubMed] [Google Scholar]
- 32.Poppi L. A., et al. , A cadherin mutation in Celsr3 linked to Tourette Disorder affects dendritic patterning and excitability of cholinergic interneurons. bioRxiv [Preprint] (2022). 10.1101/2022.03.06.483205 (Accessed 5 November 2023). [DOI]
- 33.Abdurakhmanova S., Chary K., Kettunen M., Sierra A., Panula P., Behavioral and stereological characterization of Hdc KO mice: Relation to Tourette syndrome. J. Comp. Neurol. 525, 3476–3487 (2017). [DOI] [PubMed] [Google Scholar]
- 34.Kataoka Y., et al. , Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J. Comp. Neurol. 518, 277–291 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lennington J. B., et al. , Transcriptome analysis of the human striatum in Tourette syndrome. Biol. Psychiatry 79, 372–382 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Brady M. V., et al. , Mispatterning and interneuron deficit in Tourette Syndrome basal ganglia organoids. Mol. Psychiatry 27, 5007–5019 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Rapanelli M., Frick L. R., Pittenger C., The role of interneurons in autism and Tourette syndrome. Trends Neurosci. 40, 397–407 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Rapanelli M., et al. , Targeted interneuron depletion in the dorsal striatum produces autism-like behavioral abnormalities in male but not female mice. Biol. Psychiatry 82, 194–203 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Xu M., Li L., Pittenger C., Ablation of fast-spiking interneurons in the dorsal striatum, recapitulating abnormalities seen post-mortem in Tourette syndrome, produces anxiety and elevated grooming. Neuroscience 324, 321–329 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Xu M., et al. , Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome. Proc. Natl. Acad. Sci. U.S.A. 112, 893–898 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.McCairn K. W., Bronfeld M., Belelovsky K., Bar-Gad I., The neurophysiological correlates of motor tics following focal striatal disinhibition. Brain 132, 2125–2138 (2009). [DOI] [PubMed] [Google Scholar]
- 42.McCairn K. W., et al. , A primary role for nucleus accumbens and related limbic network in vocal tics. Neuron 89, 300–307 (2016). [DOI] [PubMed] [Google Scholar]
- 43.Singer H. S., Butler I. J., Tune L. E., Seifert W. E. Jr., Coyle J. T., Dopaminergic dsyfunction in Tourette syndrome. Ann. Neurol. 12, 361–366 (1982). [DOI] [PubMed] [Google Scholar]
- 44.Maia T. V., Conceicao V. A., The roles of phasic and tonic dopamine in tic learning and expression. Biol. Psychiatry 82, 401–412 (2017). [DOI] [PubMed] [Google Scholar]
- 45.Wong D. F., et al. , Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: Clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 33, 1239–1251 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Malison R. T., et al. , [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette’s disorder. Am. J. Psychiatry 152, 1359–1361 (1995). [DOI] [PubMed] [Google Scholar]
- 47.Gilbert D. L., et al. , Altered mesolimbocortical and thalamic dopamine in Tourette syndrome. Neurology 67, 1695–1697 (2006). [DOI] [PubMed] [Google Scholar]
- 48.Minzer K., Lee O., Hong J. J., Singer H. S., Increased prefrontal D2 protein in Tourette syndrome: A postmortem analysis of frontal cortex and striatum. J. Neurol. Sci. 219, 55–61 (2004). [DOI] [PubMed] [Google Scholar]
- 49.Yoon D. Y., Gause C. D., Leckman J. F., Singer H. S., Frontal dopaminergic abnormality in Tourette syndrome: A postmortem analysis. J. Neurol. Sci. 255, 50–56 (2007). [DOI] [PubMed] [Google Scholar]
- 50.Abi-Jaoude E., et al. , Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study. Hum. Brain Mapp. 36, 2592–2601 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Mink J. W., Neurobiology of basal ganglia and Tourette syndrome: Basal ganglia circuits and thalamocortical outputs. Adv. Neurol. 99, 89–98 (2006). [PubMed] [Google Scholar]
- 52.Robertson M. M., A personal 35 year perspective on Gilles de la Tourette syndrome: Assessment, investigations, and management. Lancet Psychiatry 2, 88–104 (2015). [DOI] [PubMed] [Google Scholar]
- 53.Pogorelov V. M., Rodriguiz R. M., Insco M. L., Caron M. G., Wetsel W. C., Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology 30, 1818–1831 (2005). [DOI] [PubMed] [Google Scholar]
- 54.Shiotsuki H., et al. , A rotarod test for evaluation of motor skill learning. J. Neurosci. Methods 189, 180–185 (2010). [DOI] [PubMed] [Google Scholar]
- 55.Niv Y., Cost, benefit, tonic, phasic: What do response rates tell us about dopamine and motivation? Ann. N Y Acad. Sci. 1104, 357–376 (2007). [DOI] [PubMed] [Google Scholar]
- 56.Michely J., et al. , The role of dopamine in dynamic effort-reward integration. Neuropsychopharmacology 45, 1448–1453 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Palminteri S., et al. , Pharmacological modulation of subliminal learning in Parkinson’s and Tourette’s syndromes. Proc. Natl. Acad. Sci. U.S.A. 106, 19179–19184 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Delorme C., et al. , Enhanced habit formation in Gilles de la Tourette syndrome. Brain 139, 605–615 (2016). [DOI] [PubMed] [Google Scholar]
- 59.Markowitz J. E., et al. , Spontaneous behaviour is structured by reinforcement without explicit reward. Nature 614, 108–117 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Cross-Disorder Group of the Psychiatric Genomics Consortium, Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell 179, 1469–1482.e11 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Steinman S. A., et al. , Prepulse inhibition deficits only in females with obsessive-compulsive disorder. Depress Anxiety 33, 238–246 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Garcia-Delgar B., et al. , Tic disorders in children and adolescents: Does the clinical presentation differ in males and females? A report by the EMTICS group. Eur. Child Adolesc. Psychiatry 31, 1539–1548 (2022). [DOI] [PubMed] [Google Scholar]
- 63.Garris J., Quigg M., The female Tourette patient: Sex differences in Tourette Disorder. Neurosci. Biobehav. Rev. 129, 261–268 (2021). [DOI] [PubMed] [Google Scholar]
- 64.Lichter D. G., Finnegan S. G., Influence of gender on Tourette syndrome beyond adolescence. Eur. Psychiatry 30, 334–340 (2015). [DOI] [PubMed] [Google Scholar]
- 65.Bohic M., et al. , Mapping the neuroethological signatures of pain, analgesia, and recovery in mice. Neuron 111, 2811–2830.e8 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Nasello C., et al. , Human mutations in high-confidence Tourette disorder genes affect sensorimotor behavior, reward learning, and striatal dopamine in mice. Zenodo. 10.5281/zenodo.10974583. Deposited 15 April 2024. [DOI] [PMC free article] [PubMed]
- 67.Thackray J., et al. , tischfieldlab/moseq-reports: Gradwell_Neuron_2024. Zenodo. 10.5281/zenodo.10480907. Deposited 10 January 2024. [DOI]
- 68.Thackray J., tischfieldlab/med-associates-utils: Nasello_PNAS. Zenodo. 10.5281/zenodo.10974571. Deposited 15 April 2024. [DOI]
- 69.Thackray J., tischfieldlab/moseq2-lda: v0.0.1. Zenodo. 10.5281/zenodo.10480885. Deposited 10 January 2024. [DOI]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All study data are included in the article and/or SI Appendix. Additional raw data and information pertaining to MoSeq behavioral data sets and reward learning have been deposited at Zenodo and are publicly available as of the date of publication (66–69).